Chief Medical Officer (Adult Cancers), UTRx Inc. “The validation data supports the technological abilities of engineering mRNA stability elements on the 3’UTR of oncogenes for therapeutic use,” said ...

Chief Medical Officer (Adult Cancers), UTRx Inc. “The validation data supports the technological abilities of engineering mRNA stability elements on the 3’UTR of oncogenes for therapeutic use ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — UTR Therapeutics Inc (UTRx Inc.), a drug development biotech company based in New York City, USA is pleased to announce a new milestone, the submission ...

Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai ...

Wave of Wellness Aesthetics and Laser, a med spa in the Quad cities, is now offering Emsculpt NEO, a non-invasive technology ...

DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces the promotion of Michael Barulich to ...

If the agency approves its application, the firm will begin a Phase I clinical trial in c-MYC-driven cancers in 2026.